Premium
Will oral rivaroxaban improve clinically relevant outcomes and thromboprophylaxis management in the orthopedic patient?
Author(s) -
GÓMEZOUTES A.,
SUÁREZGEA Ma. L.,
BLÁZQUEZPÉREZ A.,
POZOHERNÁNDEZ C.,
VARGASCASTRILLÓN E.
Publication year - 2009
Publication title -
journal of thrombosis and haemostasis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.947
H-Index - 178
eISSN - 1538-7836
pISSN - 1538-7933
DOI - 10.1111/j.1538-7836.2009.03618.x
Subject(s) - medicine , rivaroxaban , number needed to harm , population , orthopedic surgery , antithrombotic , thrombosis , intensive care medicine , emergency medicine , surgery , relative risk , number needed to treat , confidence interval , warfarin , environmental health , atrial fibrillation